{
  "catalogId": "a6d5ed46-5f95-40d1-89fe-d6d0b7f03f5d",
  "name": "SUNOSI 150 MG",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "172 81 37285 99",
  "treatmentDescriptions": "Sunosi is indicated to improve wakefulness and reduce excessive daytime sleepiness in adult patients with narcolepsy (with or without cataplexy).Sunosi is indicated to improve wakefulness and reduce excessive daytime sleepiness (EDS) in adult patients with obstructive sleep apnoea (OSA) whose EDS has not been satisfactorily treated by primary OSA therapy, such as continuous positive airway pressure (CPAP).",
  "termsOfIssue": "Prescription required",
  "form": "film coated tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "SOLRIAMFETOL AS HYDROCHLORIDE",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "N06BA14",
      "name": "SOLRIAMFETOL"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "SUNOSI 150 MG 28 FILM COATED TABLETS",
      "manufacturer": {
        "name": "ניאופרם",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 28.0,
        "unit": "units"
      },
      "packagingDescription": "BLISTER PVC/PCTFE",
      "shelfLife": "60",
      "storageConditions": "",
      "codes": {
        "moh": "9303",
        "yarpa": "43133",
        "pharmasoft": "23261"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 1107.90122,
        "retailMargin": 17.5,
        "maxRetailPrice": 1301.783933,
        "maxPriceWithVAT": 1536.104973
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-08-01T12:18:43.889619"
  }
}